Edward Cahill

Bio

Ed joined HLM as a partner in 2000. He was a founding partner of Cahill, Warnock & Company (now Camden Partners), a Baltimore venture capital firm, and a Managing Director of Alex. Brown & Sons, where he headed the firm’s Health Care group from 1986 to 1995. During his leadership at Alex. Brown & Sons, he and his team underwrote public offerings or provided merger advisory services for over 200 healthcare companies, including the first publicly-held managed care, outpatient surgery center, rehabilitation, behavioral health and digital health companies and numerous pioneering biopharmaceutical and medical technology innovators. Ed is a director of Binary Fountain, Carevive, Persivia, Phreesia (NYSE), and Tandem Diabetes (NASDAQ). He previously served as a director of numerous companies, including Animas Corporation (acquired by J&J), Centene Corporation (NYSE), Masimo Corporation (NASDAQ), TYRX (acquired by Medtronic) and Vets First Choice (now Covetrus : NASDAQ:CVET). He is a Trustee of Mercy Health Services and a Trustee Emeritus of Johns Hopkins Medicine and Johns Hopkins Health System, where he continues to chair the board committee on Patient Safety and Quality. Ed received an AB from Williams College and a Master of Public and Private Management degree from Yale University.